Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Kathryn E. Beckermann, Anupama Reddy et al.|Cancers|2021Cited by 16
HUMAN SAFETY AND PHARMACOLOGY OF FTY 720R. Brunkhorst, Robert Schmouder, P Lücker et al.|Transplantation|1999Cited by 11
Spatial-temporal change in quantitative total bone imaging (QTBI) and circulating tumour cells (CTCs) in metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA)G. Liu, Robert Jeraj, William Duggan et al.|Annals of Oncology|2019Cited by 0